SLC2A3 and non-small cell lung carcinoma: Unlike GLUT3, GLUT1 expression was significantly increased in gemcitabine-resistant NSCLC cells (right panel of Fig. 1K) and decreased in paclitaxel-resistant MDA-MB-231 cell lines (right panel of Fig. 1L).